Correlation Between Visa and Isofol Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Isofol Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Isofol Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Isofol Medical AB, you can compare the effects of market volatilities on Visa and Isofol Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Isofol Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Isofol Medical.

Diversification Opportunities for Visa and Isofol Medical

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Visa and Isofol is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Isofol Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isofol Medical AB and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Isofol Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isofol Medical AB has no effect on the direction of Visa i.e., Visa and Isofol Medical go up and down completely randomly.

Pair Corralation between Visa and Isofol Medical

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.15 times more return on investment than Isofol Medical. However, Visa Class A is 6.82 times less risky than Isofol Medical. It trades about 0.08 of its potential returns per unit of risk. Isofol Medical AB is currently generating about -0.26 per unit of risk. If you would invest  31,032  in Visa Class A on September 12, 2024 and sell it today you would earn a total of  373.50  from holding Visa Class A or generate 1.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Visa Class A  vs.  Isofol Medical AB

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Isofol Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Isofol Medical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Visa and Isofol Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Isofol Medical

The main advantage of trading using opposite Visa and Isofol Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Isofol Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isofol Medical will offset losses from the drop in Isofol Medical's long position.
The idea behind Visa Class A and Isofol Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance